Delineate vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-18
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionDelineateIsomorphic Labs
PricingFreemium (free tier + Professional plan from $XX/mo)Contact-based (enterprise partnerships only)
Target UsersClinical researchers, biostatisticians, operations managersLarge pharma companies, multi-billion dollar programs
Key TechnologyMulti-agent AI for clinical trial designAlphaFold-based Drug Design Engine (predictive + generative)
DeploymentSaaS, export to Word/PDF/CDISC, API on Professional planDeep collaboration model (not a product); no standalone API
IntegrationsMedidata Rave, Veeva Vault, TrialMaster, OpenClinica, REDCap, SAS, RStudio, PubMedNone documented (operates via partnerships)

If you need to create clinical trial protocols faster with compliance and integration into eClinical platforms, Delineate is the clear choice. Isomorphic Labs is for large pharma seeking AI-driven drug discovery partnerships—not a tool you can buy off the shelf. Choose based on your stage: protocol authoring (Delineate) vs. molecule design (Isomorphic).

Delineate
Delineate

AI evidence assembly and quantitative modeling for clinical pharmacology — MBMA databases, Project Optimus dose work, exposure-response

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs uses AI drug discovery models to design novel molecules and predict how candidate drugs will perform.

Visit Website
Pricing
Paid
Contact Sales
Plans
—
—
Popularity
8 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
—
Categories
🧬 Drug Discovery & Life Sciences🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Assemble evidence from FDA clinical pharmacology reviews
Assemble evidence from EMA documents including EPARs
Extract AdCom briefing documents and postmarket commitments
Extract published literature, conference papers and posters
Extract data tables and KM curves from source documents
AI graph digitization of published plots including error bars and variance
Output a structured, queryable dataset across any drug class
Run Monte Carlo simulation across agents, indications, subgroups and endpoints
Optimize dose in line with FDA Project Optimus expectations
Benchmark exposure-response against the class-level evidence base
Test whether a signal is differentiated or within class noise
Harmonize trial-level and arm-level data to consistent endpoint definitions
Dual independent extraction with formal arbitration
Verify extracted values against original source documents
Run cross-study consistency checks for covariates and endpoints
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Built on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Announced a new path to making medicines with AI
Series B announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Founded by Demis Hassabis, who serves as CEO
Integrations
Medidata Rave EDC
Veeva Vault Clinical
TrialMaster
OpenClinica
REDCap
SAS
RStudio
PubMed
ClinicalTrials.gov

What real users say: Delineate vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Delineate

55 mentions across 6 sources · 36% positive — critical (weighted across 6 sources)

Hacker News, YouTube, Product Hunt, Stack Overflow, GitHub, Lemmy

What users praise

  • • Purpose-built for the regulated clinical-trial lifecycle, not a repurposed generic AI writer
  • • Dual independent extraction with formal arbitration addresses the classic single-extractor QC gap
  • • Full audit trail on every extracted value supports submission defensibility
  • • Integrates with Medidata Rave EDC, Veeva Vault Clinical, and CDISC SDTM exports

What frustrates them

  • • No independent community review exists — all capability claims come from the vendor
  • • Name collides with at least three unrelated products, making review-hunting genuinely confusing
  • • Not a full EDC, so teams still need separate systems for data capture
  • • No published pricing means procurement friction and unknown per-study costs

Researched Sep 14, 2026

Isomorphic Labs

No verifiable community signal. We scanned public discussion on Oct 14, 2026 and found posts matching the name “Isomorphic Labs”, but could not establish that they are about this product rather than something else sharing its name. Rather than publish a score built on the wrong subject, we publish none.

Who should pick which

  • Clinical research associate at a mid-size CRO
    Pick: Delineate

    Delineate's protocol generation, feasibility assessments, and CDISC export directly streamline their daily workflow, and the integrations with Medidata and Veeva fit their existing tech stack.

  • Biostatistician designing adaptive trials
    Pick: Delineate

    Delineate offers adaptive trial design templates (Bayesian dose-finding) and endpoint selection rationale, reducing manual statistical work.

  • VP of R&D at a large pharma company
    Pick: Isomorphic Labs

    For early-stage drug discovery targeting novel protein targets, Isomorphic Labs' Drug Design Engine and AlphaFold expertise provide a competitive edge — but only through a partnership, not a product.

  • Regulatory affairs specialist
    Pick: Delineate

    Delineate's regulatory compliance checklists (FDA, EMA, ICH) and protocol summaries match their compliance needs, plus they can export to submission-ready formats.

  • Small biotech startup without pharma partnerships
    Pick: Delineate

    Isomorphic Labs is inaccessible to them due to high entry cost and partnership model. Delineate's freemium pricing and no-code custom agents allow them to accelerate trial design on a budget.

Frequently Asked Questions

Delineate vs Isomorphic Labs: which should you choose?

If you need to create clinical trial protocols faster with compliance and integration into eClinical platforms, Delineate is the clear choice. Isomorphic Labs is for large pharma seeking AI-driven drug discovery partnerships—not a tool you can buy off the shelf. Choose based on your stage: protocol authoring (Delineate) vs. molecule design (Isomorphic).

Can I use Isomorphic Labs as a standalone software or API?

No. Isomorphic Labs operates solely through deep pharma partnerships (e.g., Novartis, Johnson & Johnson). There is no public API or self-service product.

Does Delineate integrate with my existing EDC system?

Yes. Delineate integrates with Medidata Rave EDC, Veeva Vault Clinical, TrialMaster, OpenClinica, and REDCap, plus tools like SAS, RStudio, PubMed, and ClinicalTrials.gov.

Is Delineate suitable for rare disease trials?

Yes. Delineate includes rare disease agent workflows that leverage natural history comparisons, which is critical for small patient populations.

What pricing models do these tools offer?

Delineate is freemium — free tier and Professional plan (pricing undisclosed). Isomorphic Labs is contact-only; no published pricing.

Which tool is better for regulatory compliance?

Delineate provides compliance checklists for FDA, EMA, and ICH, and exports to CDISC SDTM. Isomorphic Labs does not offer compliance features — it focuses on early discovery.

Has Isomorphic Labs released a new product recently?

No. The latest news (2026-05-12) is a Series B investment; no product launch. Their Drug Design Engine remains partnership-only.

Can I generate a full protocol outline with Delineate?

Yes. Delineate's multi-agent AI generates protocol outlines, endpoint selection rationale, feasibility reports, and literature synthesis — reducing creation time from weeks to minutes.

Do these tools compete in the same space?

Not directly. Delineate targets clinical trial design and operations (Phase I-IV). Isomorphic Labs targets early drug discovery (target identification, lead optimization).

More Delineate or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026